TNF and inflammatory bowel disease: The results showed that across 4 vaccine doses, patients with IBD treated with anti-TNF had significantly reduced S-specific IgG levels, compared with patients with IBD treated with anti-IL-12/23 and people in the healthy control group (Figure 5D), consistent with our earlier studies (8, 9).